A5050619650- Organ Donation and Transplantation
- Renal Transplantation Outcomes and Treatments
- Organ Transplantation Techniques and Outcomes
- Renal and Vascular Pathologies
- Cardiac, Anesthesia and Surgical Outcomes
- Palliative Care and End-of-Life Issues
- Cardiac and Coronary Surgery Techniques
- Neuroblastoma Research and Treatments
- Blood groups and transfusion
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Sarcoidosis and Beryllium Toxicity Research
- Adrenal Hormones and Disorders
- Trace Elements in Health
- Pneumocystis jirovecii pneumonia detection and treatment
- Medical History and Innovations
- Peripheral Neuropathies and Disorders
- Vascular Procedures and Complications
- Pregnancy and Medication Impact
- Aluminum toxicity and tolerance in plants and animals
- Hematological disorders and diagnostics
- Reconstructive Surgery and Microvascular Techniques
- Blood donation and transfusion practices
University of Utah
2023
Craigavon Area Hospital
1977
Bristol Institute for Transfusion Sciences
1971
Royal Victoria Eye and Ear Hospital
1969
Massachusetts General Hospital
1966
Harvard University
1966
UCLA Medical Center
1966
Oklahoma State University Center for Health Sciences
1966
In the first eleven months of National Organ Matching and Distribution Service 455 kidney transplants were notified. A high proportion failed within seven days operation, probably reflecting low quality some donor kidneys supplied. To improve results renal transplantation to serve increasing number potential recipients registered with service, as well obtain optimum blood tissue group compatibility recipient, many more are needed.
Hand-sutured (HS) techniques remain the gold standard for most microvascular anastomoses in microsurgery. HS can result endothelial lacerations and back wall suturing, leading to complications such as thrombosis free tissue loss. A novel force-interference-fit vascular coupling device (FIF-VCD) system potentially reduce need improve end-to-end anastomosis. This study aims describe development testing of a FIF-VCD 1.5 4.0 mm outside diameter arteries veins.